Adoptive cell transfer (ACT) of purified naive, stem cell memory, and central memory T cell subsets results in superior persistence and antitumor immunity compared with ACT of populations containing more-differentiated effector memory and effector T cells. Despite a clear advantage of the less-differentiated populations, the majority of ACT trials utilize unfractionated T cell subsets. Here, we have challenged the notion that the mere presence of less-differentiated T cells in starting populations used to generate therapeutic T cells is sufficient to convey their desirable attributes. Using both mouse and human cells, we identified a T cell-T cell interaction whereby antigen-experienced subsets directly promote the phenotypic, functional, and metabolic differentiation of naive T cells. This process led to the loss of less-differentiated T cell subsets and resulted in impaired cellular persistence and tumor regression in mouse models following ACT. The T memory-induced conversion of naive T cells was mediated by a nonapoptotic Fas signal, resulting in Akt-driven cellular differentiation. Thus, induction of Fas signaling enhanced T cell differentiation and impaired antitumor immunity, while Fas signaling blockade preserved the antitumor efficacy of naive cells within mixed populations. These findings reveal that T cell subsets can synchronize their differentiation state in a process similar to quorum sensing in unicellular organisms and suggest that disruption of this quorum-like behavior among T cells has potential to […] 
Introduction
Adoptive cell transfer (ACT), the ex vivo expansion and reinfusion of antigen-specific (Ag-specific) T cells, represents a potentially curative treatment for patients with advanced cancer (1) (2) (3) (4) and viral-reactivation syndromes (1, 5, 6) . Recent progress in the ability to genetically redirect patient-derived peripheral blood T cells toward tumor and viral-associated antigens by modification with a T cell receptor (TCR) or chimeric antigen receptor (CAR) has greatly simplified the generation of therapeutic T cells (7) (8) (9) (10) . Given the clinical efficacy of T cell therapy combined with the ability of T cells to be manufactured according to standardized procedures, ACT is now poised to enter mainstream clinical practice. However, fundamental questions remain regarding the optimal source, expansion, and quality of therapeutic T cells used for transfer.
In mice, ACT of naive CD8 + T cell-derived cells (T N -derived cells) exhibits a superior capacity to expand, persist, and treat cancer compared with normalized numbers of memory T cellderived cells (T Mem cells) (11, 12) . Preclinical human studies have confirmed that T N -derived cells maintain higher levels of the costimulatory marker CD27 and the lymphoid homing markers CD62L and CCR7; they also retain longer telomeres (12) (13) (14) (15) . Each of these parameters has correlated with the likelihood that patients will obtain an objective clinical response following ACT (15) (16) (17) . Despite these findings, the majority of current T cell therapy clinical trials do not specifically enrich for defined T cell subsets, but rather utilize unfractionated T cell populations (2) . As T N cells are in the circulation of most cancer patients (13, 18) , the following question arises: is the presence of T N cells in the initial population used to generate therapeutic T cells sufficient to convey their desirable attributes, or is physical separation of T N cells from antigen-experienced subsets required to unleash the full therapeutic potential of T N -derived cells (19, 20) ? Prior investigations revealed that T N cells form homotypic clusters during T cell priming that can influence their subsequent maturation (21, 22) . However, whether antigen-experienced populations directly interact with and influence naive cell differentiation is unknown.
Adoptive cell transfer (ACT) of purified naive, stem cell memory, and central memory T cell subsets results in superior persistence and antitumor immunity compared with ACT of populations containing more-differentiated effector memory and effector T cells. Despite a clear advantage of the less-differentiated populations, the majority of ACT trials utilize unfractionated T cell subsets. Here, we have challenged the notion that the mere presence of less-differentiated T cells in starting populations used to generate therapeutic T cells is sufficient to convey their desirable attributes. Using both mouse and human cells, we identified a T cell-T cell interaction whereby antigen-experienced subsets directly promote the phenotypic, functional, and metabolic differentiation of naive T cells. This process led to the loss of less-differentiated T cell subsets and resulted in impaired cellular persistence and tumor regression in mouse models following ACT. The T memoryinduced conversion of naive T cells was mediated by a nonapoptotic Fas signal, resulting in Akt-driven cellular differentiation. Thus, induction of Fas signaling enhanced T cell differentiation and impaired antitumor immunity, while Fas signaling blockade preserved the antitumor efficacy of naive cells within mixed populations. These findings reveal that T cell subsets can synchronize their differentiation state in a process similar to quorum sensing in unicellular organisms and suggest that disruption of this quorum-like behavior among T cells has potential to enhance T cell-based immunotherapies.
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As the frequency of circulating T Mem cells to T N cells can vary widely in patients (18, 29, 30) , we evaluated the dose dependency of T Mem cell-induced phenotypic maturation of T N cells. We activated T N cells alone or in titrated ratios with a bulk (CD44 + ) T Mem cell population. Similar to results using fractionated T CM and T EM cell subsets, we found that priming T N cells in a 1:1 mixture with bulk T Mem cells caused an increase in the T EM To determine whether CD62L loss on T N -derived cells was attributable to genetic downregulation rather than proteolytic cleavage, we reisolated Ly5.1 + T Nderived cells following expansion by FACS sorting and performed quantitative PCR (qPCR). We found that expression of selectin L (Sell), the gene encoding CD62L as well as other T N cell-associated lymphoid-homing and costimulatory markers, including Ccr7 and Cd27, was significantly downregulated in T N -derived cells expanded with T Mem cells relative to T N cells expanded alone (Figure 2C) . Additionally, we found that T N -derived cells primed with T Mem cells were more functionally differentiated, as evidenced by increased granzyme B content ( Figure 2D ) and enhanced IFN-γ secretion following stimulation with either PMA/ionomycin or hpg100 [25] [26] [27] [28] [29] [30] [31] [32] [33] Tables 1 and 2 ). In contrast, only 0 and 10 transcripts were differentially expressed by these criteria in T Mem cells expanded alone or with T N cells at these time points (Supplemental Table 3 ), indicating that the predominant outcome of this T cell-T cell interaction was T Mem cell-induced changes in T N cells. Examination of specific genes revealed that key naive and memory-associated transcription factors (TFs), including transcription factor 7 (Tcf7) (27) , Kruppel-like factor 2 (Klf2) (31) , and forkhead box O1 (Foxo1) (32) , were significantly downregulated in T N cells primed with T Mem cells compared with T N cells primed alone (Figure 2H) . Conversely, genes encoding effector-associated TFs and molecules, such as T-box 21 (Tbx21) (33), PR domain containing 1, Using human and mouse T cells, we describe here a previously unrecognized T cell-T cell interaction whereby T Mem cells directly influence T N cell differentiation during priming. This process, which we term precocious differentiation, synchronizes the behavior of T N -derived cells with T Mem cells, resulting in accelerated functional, transcriptional, and metabolic differentiation of T N cell progeny. Precocious differentiation was cell-dose, contact, and activation dependent. Mechanistically, the phenomenon was mediated by nonapoptotic Fas signaling, resulting in activation of Akt and ribosomal S6 protein (S6), kinases responsible for cellular differentiation and metabolism (23) . Consequently, induction of Fas signaling in the absence of T Mem cells enhanced differentiation and impaired antitumor immunity, while isolation of T N cells prior to priming or blockade of Fas signaling prevented T Mem cellinduced precocious differentiation and preserved the antitumor efficacy of T N -derived cells. Collectively, our results reveal that unleashing the therapeutic potential of T N -derived cells for adoptive immunotherapy necessitates disruption of intercellular communication with T Mem cells, a finding with direct implications for the design and execution of ACT clinical trials. Figure 1A ). Naive pmel-1 cells were subsequently expanded alone or in the presence of T CM or T EM cells using anti-CD3/CD28 antibodies and IL-2, which is similar to many current human ACT protocols (15, 25, 26) .
Results

T
Following expansion, the progeny of isolated T N cells had differentiated into all 3 antigen-experienced subsets, including T stem cell memory cells (T SCM cells; CD44 Figure 1B , and Supplemental Figure 1 ; supplemental material available online with this article; doi:10.1172/JCI81217DS1). Strikingly, we found that the presence of T Mem cells during T N cell priming caused a significant accumulation of T EM cells and an attrition of T SCM cells ( Figure 1C ). Both T CM and T EM cell subsets were equally capable of augmenting the phenotypic maturation of T N -derived progeny, demonstrating that this prodifferentiation capacity was a property of T Mem cell subsets in general. These findings were not attributable to differences in cell expansion, were not TCR specific, and occurred regardless of growth and cytokine conditions tested (Supplemental Figures 2  and 3) . Augmented T N cell differentiation was also observed when a CD4-containing bulk T Mem cell population was used, although the magnitude of change was less than that observed using CD8 + T Mem cells (Supplemental Figure 4) . jci. ) of T N cells were transferred into hosts containing a 100-to 1,000-fold greater frequency of T Mem cells (35) . Under these conditions, T N cells are with ZNF domain (Prdm1) (34) , and granzyme B (Gzmb) were differentially overexpressed in T N cells primed with T Mem cells (Figure 2I) . Collectively, these data revealed that T Mem cells globally altered the differentiation program of T N cells. pared with T N cells alone ( Figure 3D ). We conclude that T Mem cells can cause precocious differentiation and impaired antitumor efficacy of T N cell-derived progeny in vivo following adoptive cotransfer.
FasL-Fas interactions mediate precocious differentiation.
We next sought to elucidate what T Mem cell factor or factors caused precocious differentiation. We determined the phenomenon was, in addition to being cell-dose dependent, also cell-contact dependent and activation dependent and could not be reproduced using supernatant transfers from restimulated T Mem cells (Supplemental Figure 6 ). Accordingly, we hypothesized that an activationinduced, cell-surface molecule on T Mem cells that can mediate costimulatory-like effects was responsible. Several members of the TNF superfamily satisfy these criteria (37) . Therefore, we interrogated our microarray analysis comparing gene expression in T Mem cells and T N cells for TNF superfamily members uniquely overexpressed in activated T Mem cells to generate a list of candidate ligands. Among the 19 known TNF superfamily ligands (37) , only Fasl met criteria (log 2 FC > 2, P < 0.01) for being differentially expressed in restimulated T Mem cells ( Figure 4A and Supplemental Table 4 ). To determine whether T CM and T EM cells are similarly poised to express FasL following activation, we performed ChIPseq analysis to assess histone H3 methylation dynamics at the Fasl locus within resting T N , T CM , and T EM cell subsets. Consistent with previous reports (38), we found that T N cells exhibited strong depo- Figure  3A ). In addition to cells, recipient mice also received rVV-gp100 vaccination and exogenous IL-2. We found that both the expansion and persistence of T N cell-derived progeny were significantly impaired when cotransferred with T Mem cells ( Figure 3B ). In contrast, the recall response of cotransferred T Mem cells was not affected compared with T Mem cells transferred alone (Supplemental Figure  5 ). These findings were not due to a failure of T N cells to become primed in vivo, as a significantly larger proportion of the T N -derived population cotransferred with T Mem cells lost CD27 expression and acquired the senescent marker killer cell lectin-like receptor subfamily G1 (KLRG1) at the conclusion of the immune response compared with T N cells transferred alone ( Figure 3C ). Importantly, both tumor regression and animal survival were significantly impaired (P < 0.05) in mice receiving T N cells and T Mem cells together com- Nonapoptotic Fas signaling mediates precocious differentiation. To evaluate whether FasL-delivered signals were sufficient to induce precocious differentiation, we primed T N cells in the absence of T Mem cells with titrated amounts of recombinant FasL oligomerized through a leucine zipper domain (lz-FasL) (45) . We found that lz-FasL caused a dose-dependent increase in the differentiation of T N cell-derived progeny, as evidenced by an increased frequency of T EM cells and enhanced IFN-γ release upon restimulation ( Figure 6, A and B) . Moreover, we observed commensurate changes in the expression of key differentiation-associated genes, including Sell, Il7ra, Klf2, transferrin receptor (Tfrc), and Gzmb, as the concentration of lz-FasL was titrated up (Supplemental Figure 8) . Consistent with the apoptosis-inducing function of FasL, exposure to lz-FasL resulted in reduced cell yields, particularly at concentrations greater than 33 ng/ml ( Figure 6C ). Despite this effect, we measured a significant increase in the relative numbers of T EM cell phenotype/IFN-γ + cells following lz-FasL exposure at 33 ng/ml compared with vehicle control ( Figure 6D) . Importantly, the increase in absolute numbers of T EM cells occurred despite this subset's enhanced susceptibly to lz-FasL-induced apoptosis relative to other subsets (Supplemental Figure 9) . The differential death of T EM cells was not attributable to differences in surface Fas expression between memory subsets (Supplemental Figure 10) , a finding consistent with published studies of Fas expression on human T Mem cell subsets (45) . Collectively, these data suggested that skewing toward the T EM cell phenotype could not be accounted for solely by selective culling of T SCM and T CM cells. We next sought to determine whether Fas-mediated cellular differentiation and cell death could be uncoupled using a genetic approach. Previous work established that Fas-induced apoptosis requires posttranslational palmitoylation of a cysteine residue located within the proximal cytoplasmic region of the receptor (46, 47) . In cell lines, transfection of a Fas construct substituting a valine for a cysteine residue at the 194 position (C194V) prevented both Fas incorporation into membrane rafts and Fas-dependent apoptosis (46) . Based on these data, a transgenic mouse expressing the FasC194V variant was generated, backcrossed to the lpr background (henceforth, FasC194V lpr/lpr ), and used to derive CD8 + T cells for further analyses. Whereas lz-FasL caused dose-dependent death of WT CD8 + T cells, FasC194V lpr/lpr CD8 + T cells were significantly protected from apoptosis induction similarly to lpr CD8 + T cells ( Figure 6E ). However, unlike cells from the lpr mouse, which were also protected from lz-FasL-mediated precocious differentiation, FasC194V
lpr/lpr CD8 + T cells underwent enhanced conversion to a T EM cell phenotype similar to that of WT cells following priming with 40 ng/ml lz-FasL (Figure 6 , F and G). We conclude that a nonapoptotic Fas signal delivered by FasL is sufficient to induce the augmented differentiation of recently activated T N cells. (39) , including the phosphatidyl 3-kinase/protein kinase B (also known as Akt) pathway (42, 43) . Given the established role of Akt in CD8 + T cell effector differentiation (48), we focused our attention on the induction of phospho-Akt (pAkt) and phospho-ribosomal protein S6 (pS6), a kinase downstream of Akt signaling in T cells (23) . Compared with resting T N cells, naive cells activated for 24 hours with CD3/CD28-specific antibodies exhibited augmented staining with phospho-specific antibodies against both the T308 and S473 activation residues on Akt as well as pS6 (Figure 7, A-C) . Importantly, when Ly5.2 + T N cells were primed in the presence of congenically distinguishable Ly5.1 + T Mem cells, we observed a significant increase in the staining intensity of pAkt T308, pAkt S473, and pS6 in T N -gated cells. To establish whether increased pAkt content in T N cells primed with T Mem cells leads to commensurate changes in gene expression, we returned to our microarray analyses. Within 18 hours of T N cell activation in the presence of T Mem cells, we observed significant alterations in the expression of known targets of Akt signaling, including Il7r (49), sphingosine-1-phosphate receptor 1 (S1pr1) (50) , Tfrc (51), hexokinase-2 (Hk2) (52) , and solute carrier family 2 (Slc2a1, also known as Glut1) (ref. 53 and Figure 7D ). Based on these data, we next tested to determine whether provision of lz-FasL to activated T N cells was sufficient to augment pAkt in the absence of T Mem lpr/lpr CD8 + T cells were expanded with CD3/CD28-specific antibodies and IL-2 alone or with 40 ng/ml of lz-FasL for 6 days; n = 6-9 independently maintained cultures/cell type. Statistical comparisons performed using an unpaired 2-tailed Student's t test corrected for multiple comparisons by a Bonferroni adjustment. *P < 0.05; **P < 0.01. Results are representative of 6 (A), 2 (C-E), and 4 (F and G) independently performed experiments and are displayed as mean ± SEM. jci.org Volume 126
Precocious differentiation is associated with induction of
Number 1 January 2016 ric Akt inhibitor (48, 55) . We found that AktI significantly limited lz-FasL-mediated precocious differentiation, as evidenced by a reduced accumulation of T EM cell phenotype and IFN-γ + cells (Figure 7 , H-J). We conclude that T Mem cell and lz-FasL-induced precocious differentiation of T N cells is associated with augmented Akt pathway activation. Pharmacologic inhibition of Akt can partially block the precocious differentiation phenotype.
Human T Mem cells induce precocious differentiation of T N -derived cells.
To evaluate the relevance of precocious differentiation for human ACT trials, we next tested to determine whether human Figure 8B and Supplemental Figure 11A ). Labeled T cells were expanded alone or together in titrated ratios using CD3/CD28-specific antibodies and IL-2. Although this approach did not allow for indelible cell tracking, we found we could reliably distinguish each population for up to 6 days.
Four days following activation, T N cells and T Mem cells lost membrane dye intensity, indicating both subsets had undergone cell division. To determine whether human T N cells expand at the same rate in the presence or absence of memory cells, we calculated the proliferation index (PI) of T N -derived cells primed alone or with different ratios of T Mem cells. We discovered that human T Mem cells caused a dose-dependent increase in T N cell proliferation (Supplemental Figure 11B) . To ascertain whether T Mem cells influence T N cell differentiation independently of cell proliferation, we gated on T N -derived cells that had undergone an equivalent number of cell divisions ( Figure 8C ). We then evaluated the coordinate expression of naive-associated phenotypic markers (CD27, CCR7, CD45RA) by flow cytometry using a Boolean gating strategy. We found across all donors tested that, when normalized for division history, there was a significant dose-dependent loss of T N cells (CD27
) as the ratio of T Mem cells was increased (P = 0.0015) ( Figure 8D ). Similar conclusions were reached regardless of the generation number evaluated (data not shown). We conclude that human T Mem cells augmented both the proliferation and differentiation of T N -derived cells. Further, we conclude that the rate of differentiation is enhanced even when division history is normalized.
In mice, we discovered that T Mem cell-induced precocious differentiation of T N cells was mediated by FasL. To determine whether enhanced Fas signaling augmented the differentiation of human CD8 + T cells, we primed peripheral blood CD8 + T cells from HDs with CD3/CD28-specific antibodies and IL-2 alone or in the presence of titrated concentrations of lz-FasL. After 9 to 10 days, we found that all expanded cells had assumed a CD45RA lo/-
CD45RO
+ memory phenotype (data not shown). Using coexpression of CD27 and CCR7 (29) Fas signaling controls T cell differentiation and antitumor efficacy. T Mem -induced precocious differentiation of T N -derived cells resulted in impaired antitumor efficacy in mice. Given our findings that precocious differentiation is mediated by FasL-Fas interaction, we next tested to determine whether modulation of Fas signaling could influence the therapeutic potential of adoptively transferred T N -derived cells. We therefore primed pmel-1 T N cells in the presence of congenically distinguishable T Mem cells in combination with αFasL or IgG control. In addition, we also primed T N cells alone with lz-FasL or vehicle control. Following expansion, equal numbers of viable CD8 + T cells obtained using a density separation media for each culture condition were adoptively transferred into sublethally irradiated mice bearing 10-day established B16 melanomas in combination with rVV-gp100 and IL-2. We found that FasL blockade during T N cell expansion in the presence of T Mem cells significantly improved tumor regression (P = 0.009) and animal survival (P < 0.05), nearly rescuing the in vivo antitumor potential of isolated T N cells (Figure 10, A and B) . In contrast, FasL blockade had no impact on the antitumor efficacy of isolated T N cells expanded without T Mem cells (Supplemental Figure 13) . Conversely, augmenting Fas signaling using lz-FasL during T N cell priming significantly impaired tumor regression (P < 0.01) and animal survival (P < 0.05). The differences in treatment efficacy of lz-FasL primed T N cells were not attributable to impaired cell engraftment, as a similar frequency of cells was recovered 18 hours after transfer ( Figure 10C ). Overall, we found a significant inverse linear correlation between the state of T cell differentiation, as CD27 -). Consistent with experiments using mouse T cells, we found that augmenting Fas signaling using lz-FasL in HD cells caused a significant and dose-dependent accumulation of the more-differentiated T EM cell subset and an attrition of T CM cells ( Figure 9, A and B) . These changes were not attributable to differences in proliferation, as T cells expanded in lz-FasL and vehicle control diluted a membrane-associated dye similarly (Supplemental Figure 12A ). Moreover, analysis of the surface phenotype of T cells that had undergone an identical number of divisions revealed that lz-FasL exposure resulted in a more-differentiated phenotype compared with cells expanded in vehicle control (Supplemental Figure 12B) . Consistent with the apoptosis-inducing functions of Fas, lz-FasL resulted in a reduced cell yield at concentrations of 20 ng/ml or more (Supplemental Figure 12C) . However, at lower concentrations of lz-FasL, we measured differences in the distribution of T cell subsets while expanding similar numbers of cells. To exclude that the observed changes in human CD8 + T cell subset composition were due to selective T CM cell killing, we evaluated the induction of apoptosis (as measured by coordinate 7-AAD and annexin V staining) in T CM and T EM cell subsets following stimulation with titrated amounts of lz-FasL ( some conditions (65) . Our findings that T cells derived from lpr mice or were protected from precocious differentiation combined with the ability of lz-FasL to mediate the phenomenon excluded reverse signaling as a mechanism in our system. While Fas is conventionally known as a death receptor, its ability to mediate nonapoptotic functions has been documented in a variety of tissues (39) , including T cells (40) . We provide several lines of evidence that our findings were not attributable solely to Fas-induced apoptosis. First, we determined that T EM cells, the population that accumulates in response to augmented Fas signaling, was most sensitive to Fas-mediated apoptosis relative to other T cell subsets in both mice and humans. This finding is in agreement with previously reported results (45) . Thus, selective culling of T SCM and T CM cells could not account for the skewing toward the T EM cell population. Second, using CD8 + T cells derived from a transgenic mouse expressing a FasC194V mutant receptor, we provide genetic evidence that Fas-mediated cell death and cellular differentiation can be uncoupled by impairing the ability of the receptor to undergo posttranslational lipid modification. Although further studies are required to resolve the precise signaling cascade necessary for Fas-induced precocious differentiation, we found that both T Mem cells and lz-FasL augmented Akt signaling in T N cells. Similarly to previously reported Akt-dependent functions of canonical costimulatory molecules such as CD28 (66), augmenting Fas signaling in T N cells enhanced cellular differentiation and promoted a glycolytic metabolism. Conversely, inhibition of Akt using a well-validated allosteric inhibitor largely prevented lz-FasL-induced differentiation of T N cells, further implicating Akt activation in Fas-mediated differentiation. These findings parallel recent reports of Akt-mediated nonapoptotic Fas signaling in glioblastoma (42) and neuronal stem cells (43) .
We determined that the capacity to induce precocious differentiation was a generalized property of antigen-experienced T cells, regardless of whether they were T CM or T EM cells. These findings were associated with a permissive epigenetic signature at the FasL locus in both T CM and T EM cell subsets relative to T N cells. Further, we resolved that precocious differentiation required both cell activation and direct cell contact between T cell subsets to occur. Separation of T N and T Mem cells by a semipermeable membrane prevented the phenomenon and transfer of T Mem cell-derived supernatant to T N cells could not reproduce the effect. Recent multiphoton microscopy studies have revealed that T N and T CM cells form stable clusters together in vivo around antigen-bearing targets (67, 68) . Additionally, while lymphoid-trafficking of the CD62L -T EM / T Eff cell subsets is limited in the steady state, inflamed lymph nodes become permissive to entry of these cells (69) . Thus, there is evidence that T N and T Mem cells can physically interact with one another in vivo. Whether such T N and T Mem cell interactions might also influence the response to intracellular pathogens or vaccines under certain conditions is the subject of future work.
A prior study evaluated the influence of preexisting T cell memory on the recruitment and differentiation of T N cells in vivo (35) . Unlike current ACT clinical protocols in which large numbers of T cells are infused in an attempt to gain control over tumor replication, this study evaluated the transfer of a limiting number of T N cells (500 cells) in hosts containing 100-to 1,000-fold greater numbers of T Mem cells. Under these conditions, T Mem cells numerimeasured by CD62L expression on transferred T cells primed with FasL blockade or augmentation, and tumor growth (R 2 = 0.797, P < 0.0001; Figure 10D ). These data suggest that FasL-mediated perturbations in T cell differentiation were highly correlated with the antitumor treatment efficacy of transferred CD8 + T cells. We conclude that the negative influence of T Mem cell-induced precocious differentiation on the treatment efficacy of adoptively transferred T N -derived cells in mice is mediated by a FasL-Fas interaction that can be rescued with FasL blockade during cell expansion.
Discussion
Herein, we present evidence using both human and mouse cells that antigen-experienced CD8 + T cells directly influence naive cell differentiation both during cell expansion ex vivo and following adoptive cotransfer in vivo. This process, which we have termed precocious differentiation, serves to synchronize the functional, transcriptional, and metabolic state of T N -derived progeny with that of T Mem cells. Consequently, precocious differentiation leads to an attrition of the highly potent T SCM and T CM populations and an accumulation of T EM cells, resulting in the impaired proliferation, persistence, and antitumor treatment efficacy of adoptively transferred T cells.
In multiple preclinical models, minimally differentiated T N , T SCM , and T CM cell subsets exhibit superior persistence (12, 18, 27, (59) (60) (61) (62) and enhanced antitumor (18, 27, 59) , antibacterial (62) , and antiviral responses following ACT compared with the highly differentiated T EM cell and effector T cell (T Eff ) populations. Despite these data, the vast majority of current ACT trials utilize unfractionated T cell populations (2, 20) . Largely, this is based on an assumption that having at least some representation of the less-differentiated subsets in the starting population used to generate therapeutic T cells is sufficient to convey their desirable attributes. Our data directly challenge this notion by demonstrating that T N cells must either be isolated from T Mem cells prior to cell expansion or have their capacity to respond to T Mem cell-mediated signaling disrupted to preserve their full therapeutic potential. Accomplishing these goals at a clinical scale might be done using several strategies. These include isolating defined T cell subsets from peripheral blood using serial positive enrichments with reversible Fab streptamers (63) , employing a combination of negative and positive magnetic bead isolations (64), and antagonizing Fas or Akt signaling (55) . Based on the data in this manuscript, we have initiated a human clinical trial registered at ClinicalTrials.gov (NCT02062359) in which T N cells are enriched relative to T Mem cells using magnetic bead isolation of CD62L-expressing cells prior to gene engineering with a TCR recognizing the cancer-germline antigen NY-ESO-1. Results from this and other planned clinical trials will determine whether ACT of naiveenriched T cells results in superior clinical outcomes compared with transfer of unselected T cell populations.
Mechanistically, we identified the TNF superfamily member FasL, which is expressed on T Mem cells but not T N cells acutely following activation, as the mediator of precocious differentiation. . Apoptosis and specific cell death in defined T cell subsets was assessed using fluorochrome-conjugated annexin V and 7-AAD (both from BD Biosciences), as previously described (45) . Where indicated, T N -derived and T Mem -derived subsets were reisolated for additional analyses by FACS sorting to greater than 92% purity using FACS sorting or magnetic bead isolation. Cell viability was determined using PI exclusion in FACS-sorting experiments or fixable live/dead cells (Invitrogen) for diagnostic experiments. For FACS-based glucose uptake assays, we incubated CD8 + T cells with 100 μM 2-NBDG (Invitrogen) for 2 hours before measuring by FACS, as previously described (54 The magnitude of accelerated T N cell differentiation caused by T Mem cells was remarkably sensitive to the ratio of the 2 subsets such that an exponential relationship existed between the extent to which T N -derived progeny entered the T EM /T EFF pool and the starting proportion of T Mem to T N cells. In this manner, moredifferentiated T cell subsets have the capacity to synchronize their phenotype, function, and gene expression with less-differentiated subsets. Some unicellular organisms exhibit collective decision making through cell-cell communication once a threshold concentration of members detect an environmental stress (71) . This process, termed quorum sensing, allows individual members of a community to exhibit collectivist behaviors in order to coordinate expression of energetically expensive processes involved in virulence and differentiation (71) . While quorum sensing has been theorized to be relevant to understanding lymphocyte behavior (72, 73) , our data add to growing experimental data demonstrating that, under certain circumstances, T cells can also exhibit collectivist behaviors (74, 75) .
In conclusion, we describe what we believe to be a previously unrecognized T cell-T cell interaction whereby antigen-experienced CD8 + T cells drive T N cell differentiation during priming through a contact-dependent mechanism involving a nonapoptotic Fas-FasL interaction. The net influence of this process synchronizes T N cell behavior with that of T Mem cells, affecting the functional, transcriptional, and metabolic differentiation of T N -derived progeny. For adoptive immunotherapies, where there is a strong inverse correlation between T cell differentiation and antitumor efficacy, the implications of our findings are clear: T Mem cause significantly enhanced differentiation of T N cells, impairing in vivo antitumor efficacy. Therefore, strategies that disrupt quorum-like behavior among T cell subsets might provide a new means of enhancing the effectiveness of T cell-based immunotherapies.
Methods
Mouse strains and animal studies. Adult (6 to 12 weeks old) female C57BL/6 (B6; Ly5. were all purchased from the Jackson Laboratory. Transgenic mice harboring the Fas C194V mutant receptor were generated via BAC containing the Fas locus, with the C194V generated by recombineering. These mice were backcrossed to lpr mice on a B6 background. Fas-jci.org Volume 126 Number 1 January 2016
into the Partek Genomic Suite using robust multichip analysis (RMA) normalization after background subtraction. One-way ANOVA was used to identify differentially expressed genes among the 4 T cell subtypes with a significant cut-off of pFDR < 0.01. Differentially expressed probe sets were selected using a FDR cut-off of 0.01 without specifying a FC criterion. ChIP-seq assays were performed as previously described (55) . Briefly, 2 × 10 7 T cell subsets isolated by FACS sorting were treated with MNase to generate approximately 20% dinucleosomes and 80% mononucleosomes. Antibodies against H3K4me3 (ab8580; Abcam) and H3K27me3 (07-449; Upstate) were used for immunoprecipitation. The ChIP DNA fragments were blunt ended, ligated to Solexa adaptors, and sequenced with the Illumina 1G Genome Analyzer with mapping to the mouse genome (build mm10) using Bowtie software. All original microarray data were deposited in the NCBI's Gene Expression Omnibus (GEO GSE56344, GSE67825, and GSE67881).
Statistics. The products of perpendicular tumor diameters were plotted as the mean ± SEM for each data point, and tumor treatment graphs were compared by using the Wilcoxon rank sum test and analysis of animal survival assessed using a log-rank test. Regression analysis of the slope of tumor regression as a function of CD62L + cells among Fas-modulated CD8 + T cells was performed as described previously (78) . For all other experiments, data were compared using either an unpaired 2-tailed Student's t test corrected for multiple comparisons by a Bonferroni adjustment or repeated measures 1-way ANOVA, as indicated. In all cases, P values of less than 0.05 were considered significant. Statistics were calculated using Prism 5 GraphPad software (GraphPad Software Inc.). Where indicated, T N -derived and T Mem -derived subsets were reisolated for additional analyses by FACS sorting to more than 95% purity using FACS sorting or magnetic bead isolation. Transwell experiments were conducted in 24-well plates using 0.4 μm inserts (Corning Costar) with T N cells alone or in combination with T Mem cells either in the bottom well or in the Transwell insert. Cytokine release assays. We pulsed B6 splenocytes with indicated concentrations of hgp100 [25] [26] [27] [28] [29] [30] [31] [32] [33] peptide and incubated cells with T Nderived pmel-1 CD8
+ T cells at a 1:1 ratio overnight at 37°C. Supernatants were analyzed for mouse IFN-γ by ELISA (R&D Systems). qPCR and Western blot. For qPCR analysis, CD8 + T cell subsets were FACS sorted directly into RNAprotect Cell Reagent, and RNA was extracted using the QiaShredders and RNeasy Mini Kits (all from QIAGEN). cDNA was synthesized using the High Capacity RNA-tocDNA kit (Applied Biosystems), and qPCR was performed on an ABI 7500 Fast Instrument (Applied Biosystems). Gene expression was quantified using probes targeting Ccr7, Cd27, Gzmb, Il7ra, Klf2, Sell, Tbx21, Tcf7, Tfrc, and Prdm1 (Applied Biosystems). For Western blot analysis, CD8 + T cells were sorted into FCS and subsequently lysed in protease inhibitor containing RIPA buffer (Cell Signaling Technology). Protein was quantified using the Bio-Rad protein assay. We separated 30 μg of total protein on a 4% to 12% SDS-PAGE gel followed by standard immunoblotting with antibodies to pAktT308 (C31E5E; Cell Signaling Technology), GAPDH (AB2302; EMD Millipore), and horseradish peroxidase-conjugated goat antibodies to mouse and rabbit IgG (sc-2005 and sc-2004; Santa Cruz Biotechnology Inc.). Blots were developed using chemiluminescence (Thermo Fisher Scientific) and acquired using the ChemiDoc system (Bio-Rad Laboratories).
Microarray analyses and ChIP-seq. Gene-expression levels were determined using GeneChip Mouse Gene 1.0 ST arrays (Affymetrix) according to the manufacturer's protocol. 300 ng of total RNA was used as starting material for cRNA amplification using the WT Expression Kit (Life Technologies) according to the manufacturer's protocol. cDNA was reverse transcribed, fragmented, labeled using the GeneChip WT Terminal Labeling Kit (Affymetrix), and hybridized on the arrays for 18 hours according to the manufacturer's directions. Arrays were stained and washed in the Fluidics Station 400 (Affymetrix) and scanned (Affymetrix 7G). Array data were imported
